BHST BioHarvest Sciences Inc

  1. Stocks
  2. Consumer Defensive
  3. NASDAQ: BHST

Price (delayed)

$1.85

Market cap

$41.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.51

Enterprise value

$41.41M

?
Relative Growth: Rel. Growth: 51
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: 27
Relative Profitability: Rel. Profitability: 25
Highlights
BioHarvest Sciences's gross profit has surged by 62% YoY and by 28% QoQ
The revenue has surged by 59% year-on-year and by 30% since the previous quarter
BioHarvest Sciences's debt has decreased by 26% YoY but it has increased by 12% QoQ
BHST's EPS is down by 13% since the previous quarter but it is up by 11% year-on-year
BHST's quick ratio is down by 28% since the previous quarter
The net income is down by 22% QoQ and by 14% YoY
Sector: Consumer Defensive
Industry: Packaged Foods
Website: https://www.bioharvest.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of BHST

BHST stock price

How has the BioHarvest Sciences stock price performed over time
Intraday
-7.5%
1 week
-9.31%
1 month
-8.87%
1 year
-77.98%
YTD
-64.35%
QTD
-35.31%

Financial performance

How have BioHarvest Sciences's revenue and profit performed over time
Revenue
$35.48M
Gross profit
$20.91M
Operating income
-$6.38M
Net income
-$11.07M
Gross margin
59%
Net margin
-31.2%
BioHarvest Sciences's gross profit has surged by 62% YoY and by 28% QoQ
The company's operating income has shrunk by 61% QoQ and by 14% YoY
The revenue has surged by 59% year-on-year and by 30% since the previous quarter
BioHarvest Sciences's net margin has increased by 28% YoY and by 6% QoQ

Price vs fundamentals

How does BHST's price correlate with its fundamentals

Growth

What is BioHarvest Sciences's growth rate over time

Valuation

What is BioHarvest Sciences stock price valuation
P/E
N/A
P/B
2.12
P/S
1.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.17
BHST's EPS is down by 13% since the previous quarter but it is up by 11% year-on-year
The stock's price to book (P/B) is 74% less than its last 4 quarters average of 8.2
BHST's equity is down by 14% since the previous quarter
The price to sales (P/S) is 68% lower than the last 4 quarters average of 3.7
The revenue has surged by 59% year-on-year and by 30% since the previous quarter

Efficiency

How efficient is BioHarvest Sciences business performance
The ROE has soared by 99% year-on-year and by 17% since the previous quarter
The return on invested capital has dropped by 55% since the previous quarter but it has increased by 14% year-on-year
BHST's return on assets is up by 31% year-on-year but it is down by 10% since the previous quarter
BHST's return on sales is up by 31% year-on-year but it is down by 24% since the previous quarter

Dividends

What is BHST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHST.

Financial health

How did BioHarvest Sciences financials performed over time
BioHarvest Sciences's total assets is 80% more than its total liabilities
BioHarvest Sciences's total assets has soared by 60% YoY but it has decreased by 2.2% from the previous quarter
BHST's quick ratio is down by 28% since the previous quarter
BioHarvest Sciences's debt is 21% lower than its equity
BioHarvest Sciences's debt to equity has soared by 116% YoY and by 30% from the previous quarter
BioHarvest Sciences's debt has decreased by 26% YoY but it has increased by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.